IFP Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37K Buy
406
+32
+9% +$411 ﹤0.01% 3635
2026
Q1
$3.1K Buy
374
+23
+7% +$208 ﹤0.01% 3789
2025
Q4
$3.37K Hold
351
﹤0.01% 3620
2025
Q3
$3.33K Sell
351
-15
-4% -$126 ﹤0.01% 3466
2025
Q2
$2.97K Buy
366
+354
+2,950% +$2.2K ﹤0.01% 3706
2025
Q1
$73 Hold
12
﹤0.01% 3946
2024
Q4
$93 Buy
+12
New +$89 ﹤0.01% 4056
2018
Q3
Sell
-55,795
Closed -$880K 3859
2018
Q2
$880K Buy
+55,795
New +$594K 0.04% 457

Other funds holding CYRX

IFP Advisors's CYRX Position: Q2 2026 in Review

IFP Advisors increased its CryoPort (CYRX) stake by 8.6% in Q2 2026, buying an estimated $411 and bringing the position to 406 shares worth $6.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3635.

IFP Advisors first reported a position in CYRX in Q2 2018 and has held it in 8 quarters since. The position peaked at $880K in Q2 2018. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • IFP Advisors held 406 shares of CryoPort worth $6.37K as of Q2 2026.
  • IFP Advisors bought 32 CryoPort shares in Q2 2026, an estimated $411.
  • CryoPort made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3635 holding.
  • IFP Advisors first reported a position in CryoPort in Q2 2018 and has held it in 8 quarters since.
  • IFP Advisors's CryoPort position peaked at $880K in Q2 2018.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.